INTRODUCTION {#Sec1}
============

There has been a great interest in the pharmaceutical field in the use of silicates for the development of oral dosage forms, especially to enhance dissolution rate and bioavailability of poorly water soluble drugs by adsorbing them onto silicates in amorphous forms or as solutions ([@CR1]--[@CR8]). Having high surface area and commonly being porous, silicates are capable of adsorbing liquids, often as much as 2 to 3 times their own weights. They were first utilized by Jarowski *et al.* ([@CR9]) for adsorbing organic solutions of poorly water-soluble drugs, and, in more recent years, they were investigated for adsorbing self-emulsifying drug delivery systems to convert them into dry powders ([@CR10]--[@CR14]). However, such a formulation approach often led to the development of powder-filled hard gelatin capsule formulations as the silicates were inherently non-compactible or the loading of liquids prevented their compression into tablets ([@CR15]). The amount of materials that could be delivered in a unit dose of capsule was limited to a relatively low maximum amount of about 300--400 mg of powder for a capsule suitable for oral administration. On the other hand, as much as 1 g or even a higher amount of powder may be compressed into a unit tablet. Considering a tablet weight of 1 g and the liquid to silica ratio of 1:1, this would lead to a tablet with 500 mg of liquid component, which is not possible in a powder-filled capsule.

Despite obvious advantages of tablet formulations, there are only limited studies on the development of tablet dosage forms for lipid-based drug delivery systems reported in the literature. The poor tabletability of powders loaded with liquid lipids and surfactants into tablets has been the major development issue. Sander and Holm ([@CR3]) reported that when the liquid-loaded powders are compressed, there is a lack of tablet hardness due to the squeezing out of oily liquid from the solid, especially at the relatively high liquid load. It is, therefore, of interest to determine the tableting properties of various silicates in presence of lipids and surfactants. In two recent studies published in 2012, the tableting properties of several silicates were investigated ([@CR16],[@CR17]). Hentzschel *et al.* ([@CR16]) measured the tensile strength of four silicates, namely, Aerosil, Aerogel, Neusilin and Florite, as a function of compression pressure to determine their suitability as tableting excipients. It was observed that three of them, Aerogel, Neusilin and Florite, had acceptable tablet hardness. However, only the neat silicates or the mixtures of silicates with microcrystalline cellulose (Avicel) were used in these studies and no lipids or surfactants were added. Mura *et al.* ([@CR17]) adsorbed a self-microemulsifying formulation onto several silicates before determining their tabletability. They observed that only one of the silicate used, Neusilin® US2, had acceptable tableting properties. The lipid-based formulation used in this study consisted primarily of the mixture of a surfactant (47%) and an organic solvent (47%), and the concentration of lipid component was relatively low (6%).

The present study has been undertaken to compare six commonly available silicates from different manufactures for their tabletability after loading two medium chain lipids and a surfactant individually. The two representative lipids, Capmul® MCM EP (glycerol monocaprylocaprate) and Captex® 355 EP/NF (caprylic/capric triglycerides), and the surfactant, Cremophor® EL (PEG-35 castor oil), selected for the present study are commonly used in the development of SEDDS ([@CR18]). To date, silicates are usually used in the development of solid dosage forms as glidants to enhance flowability of powders by reducing interparticular cohesion and adhesion ([@CR19]). Therefore, all the silicates used in the present investigation were not necessarily manufactured and marketed for the application of adsorbing liquids. However, the focus of the present investigation has been the tabletability of silicates after adsorption of lipids and surfactants and no other application of the silicates was investigated. In addition to studying tabletability, the surface structure and relative particle sizes of the silicates, the nature of their pores and how the liquids were absorbed and distributed within the pores or at the surface were examined. This was done by the scanning electron microscopic (SEM) analysis of each silicate, with and without the loading of liquid. Such a SEM analysis may be able to explain the effect of adsorbed lipids and surfactants on the tabletability of different solid formulations.

MATERIALS AND METHODS {#Sec2}
=====================

Materials {#Sec3}
---------

Two medium chain lipids, Capmul® MCM EP (glycerol monocaprylocaprate) and Captex® 355 EP/NF (caprylic/capric triglycerides) were used. They were obtained from ABITEC Corp., Columbus, OH, USA. The surfactant, Cremophor® EL (PEG-35 castor oil) was obtained from BASF, Tarrytown, NY, USA. Compositions of lipids and the surfactant used and structures of their primary components were reported earlier ([@CR18]). Various silicates used, along with names of their manufacturers, are listed in Table [I](#Tab1){ref-type="table"}. The microcrystalline cellulose NF (Vivapur® 112) was obtained from JRS Pharma, Rosenberg, Germany.Table ITrade Names and Physical Characteristics of Selected Silicates Used in this StudyTrade nameAerosil® 200 PharmaNeusilin® UFL2Neusilin® US2Sipernat® 22Sylysia® 350 FCPZeopharm ®600SupplierEvonik Degussa, Parsippany, NJ, USAFuji Health Science, Burlington, NJ, USAFuji Health Science, Burlington, NJ, USAEvonik Degussa, Piscataway, NJ, USAFuji Silysia Chemical USA, LTD., Greenville, NC, USAJ.M. Huber Corporation, Atlanta, GA, USAPhysical form/chemical compositionWhite powder. Silicon dioxide (100%)^a^White powder. Magnesium aluminometasilicate: mixture of aluminum oxide (32.0%) + magnesium oxide (12.4%) + silicon dioxide (31.9%)^a^White granules. Magnesium aluminometasilicate: mixture of aluminum oxide (31.0%) + magnesium oxide (12.3%) + silicon dioxide (31.9%)^a^White powder. Silicon dioxide (98%)^a^White powder, Silicon dioxide (99.5--100%)^a^White powder. Calcium oxide (24%) + silicon dioxide (57%)^a^Mean particle size (μm)Nanosized branched chain aggregates of colloidal silicon sioxide^b^2--8^e^60--120^g^120^c^1.8^h^6^j^Oil adsorbing capacity (ml/100 g)255^c^270--340^f^270--340^f^235^c^300^a^450^a^Specific surface area (m^2^/g)200^a^300^f^300^g^190^a^300^h^300^k^Bulk Density (g/cc)\<0.05^d^0.06--0.11^f^0.13--0.18^f^--0.12--0.18^i^0.1^k^pH (4% / 5% slurry)3.5--5.5^a^ ^(4%)^6.0--8.0^f\ (4%)^6.0--8.0^f\ (4%)^6.5^a\ (5%)^6.0--8.0^a\ (5%)^9.5--10.2^a\ (5%)a^From Certificate of Analysis or MSDS of respective product.^b^Evonik Industries. AEROSIL® Colloidal Silicon Dioxide for Pharmaceuticals, Technical Information TI 1281.^c^Evonik Industries. Converting liquids to dry flowable powders and retaining flavors on SIPERNAT® specialty silica and AEROSIL® fumed silica \[Internet\]. 2012. Available from: <http://www.sipernat.com/sites/dc/Downloadcenter/Evonik/Product/SIPERNAT/TI%201367%20us.pdf>^d^From product brochure.^e^Fuji Chemical Industry Co., Ltd. Neusilin The Extraordinary Excipient for Oral Solid Dosage Forms. 2007 Oct; Available from: <http://www.fujichemical.co.jp/english/newsletter/newsletter_pharma_0710.html>^f^Fuji Chemical Industry Co., Ltd. General Properties of Neusilin. 2009 2010; Available from: <http://www.neusilin.com/product/general_properties.php>^g^Fuji Chemical Industry Co., Ltd. Neusilin The Extraordinary Excipient for Oral Solid Dosage Forms. 2007 Nov; Available from: <http://www.fujichemical.co.jp/english/newsletter/newsletter_pharma_0711.html>^h^ <http://www.aquachem.co.kr/product/Sylysia.htm>^i^Fuji Silysia Chemical LTD. Sylysia® FCP Product brochure; Available from: <http://www.tcrindustries.com/FineChemical/Principals/BROCHURES/fujibrochures/FCP%20Brochure.pdf>^j^Company product literature.^k^M. Hall (personal communication, October 19, 2011)

Tableting of Silicates without Added Lipids {#Sec4}
-------------------------------------------

Most of the available silicates are inherently non-tabletable ([@CR20]) and, as shown in Table [I](#Tab1){ref-type="table"}, have very low bulk density. The bulk density of Aerosil 200®, for example, was extremely low. Therefore, the tabletability of different silicates used in this study was compared by mixing them with 20% w/w microcrystalline cellulose NF (MCC). Since the same concentration of microcrystalline cellulose was present with all silicates, the determination of relative tabletability of different silicates was possible.

Formulations weighing *ca*. 400 mg that contained 20% w/w microcrystalline cellulose and 80% w/w silica were compressed at 50, 150 and 250 MPa using 14 mm flat face punches (Natoli Engineering, Saint Charles, MO, USA) on a single punch Carver Press assembly (Carver Inc., Wabash, IN, USA). Tablet hardness was determined using a PAH-01 hardness tester (Pharma Alliance, Valencia, CA, USA). Tablet dimensions were then used to calculate the tensile strengths (*ρ*) of the tablets using the following equation:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ \rho =2F/\pi \mathrm{DT} $$\end{document}$$where F is the breaking force, D and T are the diameter and thickness, respectively ([@CR21]). Since the hardness of tablets as determined by the hardness tester varies depending on the tablet size, the calculation of tensile strength in this way normalized the size difference.

Liquid Loading onto Silicates {#Sec5}
-----------------------------

Initially, attempts were made to incorporate the lipids and the surfactant with silicates by mixing the liquids and the silicates at 1:1 ratios in beakers with the help of a spatula or by levigating them with a mortar and a pestle. However, the process was unable to distribute lipids uniformly in some of the silicates and the powders produced in several cases resulted into lumps with poor flow properties. In several studies reported in the literature, the lipid-based formulations were adsorbed onto solid carriers by first dissolving them in volatile organic solvents and then adding dry carrier powders to these solutions, which was followed by drying of the mixtures ([@CR22],[@CR23]). A similar method was adopted in the present study for screening various silicates for their suitability as carriers for lipids and surfactants. Capmul® MCM EP, Captex® 355 and Chremophor® EL were dissolved separately in minimum necessary amounts of isopropanol. Silicates were then added to the alcoholic solution to produce slurries such that the silicate to lipid (or surfactant) ratio was 1:1 w/w. The slurries were dried by placing them on open petri dishes at room temperature in a fume hood for 2 days. The materials were mixed intermittently with a spatula to facilitate drying. Free-flowing and lump-free powders were obtained. It was confirmed by weighing the powders after drying that there was a complete evaporation of isopropanol. The powders were then passed through a sieve of 800-μm pore size before further use.

Tableting of Liquid-Loaded Powders {#Sec6}
----------------------------------

Formulations containing approximately 50% w/w silicate and 50% w/w lipid or surfactant and weighing *ca*. 800 mg were compressed at pressures ranging from 45 MPa to 270 MPa using 14 mm flat face punches (Natoli Engineering) on a single punch Carver Press assembly (Carver Inc.). No microcrystalline cellulose was added with the liquid-loaded silicates as it was found that some of the neat silicates could be compressed into hard tablets even without adding microcrystalline cellulose and the primary purpose of these experiments was to determine what effects the adsorbed liquids would have on the tabletability of silicates. Tablet tensile strength was calculated as described earlier.

Scanning Electron Microscopy (SEM) {#Sec7}
----------------------------------

### Preparation of Samples {#Sec8}

The SEM study was conducted for the neat silicates as well as for the silicate-liquid mixtures. Since the two lipids and the surfactant used behaved similarly in the tableting study, only one of them, Cremophor® EL, was used for the SEM study of mixtures. Samples with the 1:1 w/w ratio of silicate and Cremophor® EL was prepared for all silicates by the method described earlier in this paper. Additionally, 1:2 and 1:3 w/w ratios of silicate to Cremophor® EL was prepared for two of the silicates (Neusilin® US2 and Neusilin® UFL2) that showed promising tableting properties with the addition of lipid or surfactant.

### Recording of SEM Images {#Sec9}

The samples were stored in closed vials prior to analysis. SEM stubs were sterilized in acetone for 1 min, and then a light dusting of each sample was adhered to the stub using carbon tape. Next, the samples were platinum coated using an EMS 550X sputter coater (Electron Microscopy Sciences, Hatfield, PA, USA) at 25 mA. Most samples were coated for \~4 min; only a few samples were coated for \~2 min. The samples were then observed under a variety of accelerating voltages using a JEOL JSM-6010 analytical scanning electron microscope (JEOL Ltd, Tokyo, Japan). The micrographs were digitally captured at 5 and 10 kV.

RESULTS AND DISCUSSION {#Sec10}
======================

Tabletability of Silicates without Liquid Adsorption {#Sec11}
----------------------------------------------------

Tabletability may be defined as the capacity of a powder to be transformed into a tablet of specified strength under the effect of a certain compaction pressure ([@CR24]). It is typically characterized by plotting tablet tensile strength as a function of compaction pressure.

Table [II](#Tab2){ref-type="table"} shows the tabletability profiles of the selected silicates in presence of 20% MCC. To obtain a preliminary insight into the tabletability behavior of these formulations, three compaction pressures (viz. 50 MPa, 150 MPa and 200 MPa) representing a relatively wide range of compaction behavior were utilized. Tensile strength values in excess of 1 MPa are typically desired for tablets to withstand stress during their lifetime ([@CR25]). Among the silicates tested, only Neusilin® US2 and Neusilin® UFL2 could produce tablets with a tensile strength of ≥1 MPa under all three compression pressures used, while Zeopharm® 600 exhibited high tensile strengths at compression pressures of 150 and 250 MPa, which were comparable to that of Neusilin® US2 and Neusilin® UFL2. Sipernat® 22 could produce a tensile strength of 1.2 MPa at a compaction pressure of 250 MPa; however, the value was about one-fourth of that produced by Zeopharm® 600, Neusilin® UFL2 and Neusilin® US2. Aerosil® 200 and Sylysia 350® produced tablets of poor tensile strength, which broke or laminated at high pressure. Formulations of Aerosil® 200 and Sylysia 350® were also very difficult to handle due to low bulk density of materials and the tendency to form aggregates. Since very high tablet tensile strengths (\> 5 MPa) could be obtained with some of the formulations at merely 20% MCC load, addition of MCC at higher concentrations was not considered to be important in comparing tableting properties of different silicates.Table IITabletability (Tensile Strength in MPa) of Selected Silicates Blended with 20% w/w MCC (Average of 2 Determinations)Silicate used (+20% w/w microcrystalline cellulose)Tensile strength (MPa) at different compression pressure50 MPa^a^150 MPa^a^250 MPa^a^Aerosil® 2000.10.4BrokenNeusilin® UFL21.44.45.0Neusilin® US21.25.34.6Sipernat® 22Broken0.61.2Sylysia® 3500.10.9LaminatedZeopharm® 6000.65.55.0^a^Compression pressure

Tabletability of Silicates in Presence of Lipids and Surfactant {#Sec12}
---------------------------------------------------------------

Since Neusilin® US2, Neusilin® UFL2 and Zeopharm® 600 exhibited acceptable tableting properties when used without the adsorption of liquids, it was of interest to determine how will they behave when lipids and surfactants are adsorbed onto them. The tabletability of other three silicates (Aerosil 200, Sipernet 22 and Sylysia 350) was also studied to determine what effects the adsorbed lipids and surfactant would have on their tabletability.

The results of the tabletability of various silicates in presence of Capmul® MCM, Captex® 355 and Cremophor® EL are, respectively, shown in Fig. [1a, b and c](#Fig1){ref-type="fig"}. No microcrystalline cellulose was added in preparing these tablets. It is evident from the figures that only Neusilin® US2 and Neusilin® UFL2 could produce tablets with tensile strength equivalent to or higher than 1 MPa. The tablets obtained with the other silicates were soft and oily, which often laminated or capped and in some cases even stuck to the punches. However, irrespective of such anomalies, all tablets were analyzed for their tensile strengths and the values reported. Between Neusilin® US2 and Neusilin® UFL2, the later could produce acceptable tablets (\~1 MPa) at the low pressures 45 MPa and its tabletability decreased at higher pressures. Although Zeopharm® 600 produced excellent tablets in the absence of liquid load where its tensile strengths were similar to those of Neusilin® US2, it failed to produce acceptable tablets in presence of adsorbed lipids and surfactant. Indeed, the tabletability of Zeopharm® 600 in presence of the liquid was very similar to that of the other silicates that did not produce acceptable tablets without adsorbed liquids. It is, therefore, evident from Fig. [1a, b and c](#Fig1){ref-type="fig"} that Neusilin® US2 outperformed all other silicates tested in the present investigation with respect to their tabletability. Neusilin® US2 did this by exhibiting superior tensile strength at the 1:1 w/w loading of lipids and surfactant. The appearance Neusilin® US2 tablets were also excellent, irrespective of the type of liquid and the amount of compression pressure used, which ranged from 45 to 270 MPa. The tabletability of Neusilin® US2, however, decreased below the acceptable limit when the liquid load was increased to 1:2 and 1:3 w/w (data not shown). Using blends of a liquid, tocopherol acetate, and several silicates, Hentzschel *et al.* ([@CR23]) observed that, unlike most other silicates, Neusilin® US2 exhibits good tabletability. Thus, the results of the present investigation are also in agreement with previous observations by other investigators.Fig. 1Tabletability of selected carriers at 1:1 w/w ratio with **a** glycerol monocaprylocaprate (Capmul® MCM EP), **b** caprylic/capric triglyceride (Captex® 355), and **c** PEG-35 castor oil (Cremophor® EL). Each data point is the average of 2 separated determinations.

As shown in Tables [I](#Tab1){ref-type="table"} and [II](#Tab2){ref-type="table"} and also reported in the literature ([@CR20]), most silicates used in pharmaceutical products exhibit very low bulk densities and lack inherent tabletability. It was observed in the present study that there was a significant improvement in the densities of the silicates after loading of liquids (data not shown). However, such an increase in density did not have any positive impact on the tabletability of silicates. Khan *et al.* ([@CR15],[@CR26]) used additional excipients, such as microcrystalline cellulose, to increase the tabletability of silicates with adsorbed lipids and surfactants. Although helpful, such addition of other excipients increases the tablet weight and may, indeed, reduce the lipid and surfactant load and hence the drug load in the tablet drastically, especially when the drug solubility in the lipid is low or the dose is high. For this reason, the 1:1 w/w ratio of the adsorbed liquid to the silicate, without the addition of any tableting aid like microcrystalline cellulose, was selected in the present study as the initial acceptance criteria for the lipid-based tablet formulations.

Figure [2](#Fig2){ref-type="fig"} shows the effect of lipid and surfactant on the tabletability of Neusilin® US2. Since Neusilin® US2 by itself could also be compressed into tablets, the neat silicate rather than its mixture with 20% w/w microcrystalline cellulose was used for comparison with the ones containing two lipids and one surfactant. As mentioned earlier, the tabletability of Neusilin® US2 in presence of 1:1 w/w liquid load was found to be acceptable (Fig. [1a, b and c](#Fig1){ref-type="fig"}). However, the comparative data in Fig. [2](#Fig2){ref-type="fig"} demonstrate that the tabletability of Neusilin® US2 decreased drastically upon the loading of liquids (ca. 6 MPa for neat silicate at the compaction pressure of 135 MPa *versus* ca. 2 MPa in presence of liquid at the same pressure). The distinct loss of tabletability in presence of lipid and surfactant could be attributed to the interparticulate spreading of the liquid in the tablet bed, thus interfering in the bonding between silicate particles.Fig. 2Comparative tabletability of Neusilin® US2 without and with the liquid load. Data for neat Neusilin® US2 *vs.* Neusilin®US2 loaded with glycerol monocaprylocaprate (Capmul® MCM EP), caprylic/capric triglyceride (Captex® 355) and PEG-35 castor oil at 1:1 w/w ratio are shown (*n* = 1).

Effect of Type of Liquid Component on Tabletability {#Sec13}
---------------------------------------------------

The physics of adsorption of liquid solutions of drugs onto mesoporous substances like Neusilin® US2 was described and reviewed by Qian and Bogner ([@CR7]). Although the adsorption of liquids on silicates is expected to be a completely physical process, it was of interest to see if there was any effect of individual liquid components (Capmul® MCM EP, Captex® 355 and Cremophor® EL) of lipid-based drug delivery systems on the tabletability of the silicates. It may be observed from Fig. [1a, b and c](#Fig1){ref-type="fig"} that there was no difference among the three liquids (two lipids and one surfactant) used in the present study on their impact on tabletability of silicates. If at all, the difference was marginal and not significant.

Effect of Particle Size {#Sec14}
-----------------------

The exact physicochemical basis of the good tabletability exhibited by Neusilin® US2 is not known. It could possibly be attributed to its chemical composition, relatively large particle size and porous granular nature. To ascertain the effect of particle size on the tabletability of Neusilin® US2, an experiment was conducted where Neusilin® US2 was sieved through No. 120 (125 μm) and No. 325 (45 μm) sieves. One of the liquids, Cremophor® EL, was then adsorbed at the 1:1 w/w ratio onto the three sieve fractions with high, intermediate and low particle sizes of Neusilin® US2 (\>125, 45--125 and \<45 μm). As shown in Fig. [3](#Fig3){ref-type="fig"}, there was no major difference in tensile strengths of the three sieved fractions of Neusilin® US2 as the values ranged from \~1.6 to 2.1 MPa. The values were also essentially similar to that of the non-sieved material.Fig. 3Effect of particle size on the tabletability of Neusilin® US2 and Neusilin® UFL2 loaded with Cremophor® EL at 1:1 w/w ratio and compressed at 135 MPa. \*UFL2 (5 μm) compressed at 45 MPa. (*n* = 3 ± s.d.)

Since the difference in the tensile strength of different Neusilin® US2 particle fractions ranging from \<45 μm to \>125 μm was only marginal, further investigation of the effect of particle size on tabletability was conducted using Neusilin® UFL2, which is compositionally similar to Neusilin® US2 (Table [I](#Tab1){ref-type="table"}) but had a much lower particle size (\<5 μm). The results are also given in Fig. [3](#Fig3){ref-type="fig"}, showing that at the 1:1 w/w ratio with the liquids Neusilin® UFL2 exhibited poor tabletability having the tensile strength of \<1 MPa. These results presented in Fig. [3](#Fig3){ref-type="fig"} are in agreement with those observed in Fig. [1](#Fig1){ref-type="fig"}. Thus, it is apparent that a relatively large difference in particle size of the same class of silicates (for example, Neusilin® US2 *vs.* Neusilin® UFL2) can influence the tabletability of material after adsorption of lipids and surfactants. The relatively larger particle size of the same class of silicates appears to favor the development of tablet formulations for lipid-based drug delivery systems.

It is possible that when a liquid is loaded onto larger Neusilin® US2 particles most of it is adsorbed deeper inside the pores and, therefore, a relatively lesser amount covers the particle surface. On the other hand, for smaller particles the adsorbed liquid tends to stay closer to the surface of the particles and they may be squeezed out more easily by the pressure applied during tableting. As a result, the inter-particulate bonding between the carrier particles of the later systems could be heavily interfered by the presence of liquids. The decrease in tabletability of Neusilin® UFL2 with smaller particle size may, thus, be attributed to the liquids staying onto or closer to the surface of such particles. It may also explain the decrease in tensile strength with the increase in compression pressure observed for Neusilin® UFL2 in Fig. [1a, b and c](#Fig1){ref-type="fig"}. It is possible that more of the liquid squeezed out of the pores at higher compression pressure, which decreased the tensile strength of tablets.

Unlike Neusilin® US2, tablets made up of Sipernat® 22 having an average particle size of 110 μm, which is essentially similar to that of Neusilin® US2, exhibited poor tabletability (tensile strengths \<1 MPa; Fig. [1a, b and c](#Fig1){ref-type="fig"}) when loaded at 1:1 ratio with Cremophor® EL. It is, therefore, evident that certain properties of silicates other than particle size may also influence the tablet development of lipid-based systems.

SEM Study {#Sec15}
---------

Although many different studies on the adsorption of lipids and surfactants onto silicates were reported in the literature, there is no systematic investigation on why certain silicates exhibit acceptable tabletability while others do not. In the present investigation, the surface structures of six different silicates were studied, with and without the adsorption of a liquid component, for an insight into their tabletability. Although two lipids and one surfactant have been used in compression studies, Fig. [1](#Fig1){ref-type="fig"} shows that all of them have similar effects on the tabletability of silicates. All three of them also showed similar SEM micrographs when adsorbed onto silicates. Therefore, the detailed SEM studies were conducted using only PEG-35 castor oil (Cremophor® EL).

### Aerosil® 200 {#Sec16}

Figure [4](#Fig4){ref-type="fig"} shows the SEM micrographs of Aerosil® 200 as neat material and after adsoption of Cremophor® EL at 1:1 w/w ratio. The depths of the microscopic fields give a three dimensional perceptions of the SEM images. In the left hand column of Fig. [4](#Fig4){ref-type="fig"}, the top image (Fig. [4a](#Fig4){ref-type="fig"}) shows the neat material 270× magnification, which is then followed by the images of the same material at 1500× and 5500× magnifications (Fig. [4b and c](#Fig4){ref-type="fig"}, respectively). Scales of 50, 10 and 2 μm are shown in Fig. [4a, b and c](#Fig4){ref-type="fig"}, respectively, for an overview of the particle size of the material. It is apparent that Aerosil® 200 exists as loose aggregates of very fine particles. Even at the magnification of 5500× and the scale of 2 μm (Fig. [4c](#Fig4){ref-type="fig"}), the material exhibits aggregation. These results are in agreement with the description of Aerosil® 200 in Table [I](#Tab1){ref-type="table"} to be nanosized aggregates of silicon dioxide.Fig. 4SEM images of neat Aerosil® 200 at 270× (**a**), 1500× (**b**) and 5500× (**c**) magnifications and 1:1 w/w mixture of Aerosil® 200 with PEG-35 castor oil (Cremophor® EL) at 270× (**d**), 1500× (**e**) and 6000× (**f**) magnifications. A microscope scale is shown in each image for comparison of dimensions.

Unlike the neat material, Aerosil® 200 formed relatively large granules when Cremophor® EL was adsorbed onto it at 1:1 w/w ratio (Fig. [4d, e and f](#Fig4){ref-type="fig"} at, respectively, 270×, 1500× and 6000× magnifications). In contrast to the extremely fine nanosized particles of neat Aerosil® 200, the granules are much larger than 50 μm and could be as large as 300 μm (Fig. [4d](#Fig4){ref-type="fig"}). Further magnification of the surface of the granules produced (Fig. [4e and f](#Fig4){ref-type="fig"}) show that they are apparently held together by the liquid. Thus, the adsorbed oily liquid is apparently acting as the granulating agent for the Aerosil® 200 and is interspersed in between particles. This might be the mechanism how the silicates work as adsorption media for such liquids. Since particle size of Aerosil® 200 is extremely low, any possibility of the existence of sizable pores and the adsorption of lipids and surfactants into such pores appear to be low. Aerosil® 200 is not inherently tabletable. The presence of liquids at the surface of the silicate rather than inside pores and the possibility of their squeezing out under pressure from granules formed might even add to its lack of tabletability.

### Sylysia® 350 {#Sec17}

This silicate shows SEM micrographs very similar to those of Aerosil® 200. The left hand column of Fig. [5](#Fig5){ref-type="fig"} shows SEM images of Sylysia® 350 at 1500×, 3700× and 5500× (Fig. [5a, b and c](#Fig5){ref-type="fig"}, respectively) with the embedded measuring scales of 10, 5 and 2 μm, respectively. It is apparent from these images that the material exists as loose aggregates of very fine particles. Even at the scale of 2 μm (Fig. [5c](#Fig5){ref-type="fig"}), the aggregates can be distinctly observed, and the size of the individual particles appear to be much less than 1 μm. Thus, the reported particle size of 1.8 μm, as noted in Table [I](#Tab1){ref-type="table"}, seems to be higher than what we observed in the SEM images.Fig. 5SEM images of neat Sylysia® 350 FCP at 1500× (**a**), 3700× (**b**) and 5500× (**c**) magnifications and 1:1 w/w mixture of Sylysia® 350 FCP with PEG-35 Castor oil (Cremophor® EL) at 700× (**d**), 3000× (**e**) and 6000× (**f**) magnifications. A microscope scale is shown in each image for comparison of dimensions.

Again, very similar to Aerosil® 200, Sylysia® 350 forms granules in presence of Cremophor® EL at the 1:1 w/w ratio (Fig. [5d, e and f](#Fig5){ref-type="fig"} at, respectively, 700×, 3000× and 6000× magnifications) and the liquid is distributed inside as well as at the surface of the granules formed. Sylysia® 350 is inherently poorly tabletable, and the adsorption of oily liquids onto the relatively large surface area of very small particles would make the material even less tabletable.

### Zeopharm® 600 {#Sec18}

Figure [6a and b](#Fig6){ref-type="fig"} give the SEM micrographs of neat Zeopharm**®** 600 at 270× and 2500× magnifications. The reported particle size of Zeopharm**®** is 6 μm (Table [I](#Tab1){ref-type="table"}). However, at the scale of 10 μm in Fig. [6b](#Fig6){ref-type="fig"}, the material appears to be agglomerates of very fine particles and even the size of the agglomerates appears to be much less than 6 μm. It appears that the size of individual particles would be less than 1 μm and thus the particle size of Zeopharm**®** appears to be closer to those of Aerosil® 200 and Sylysia® 350. It is evident that like Aerosil® 200 and Sylysia® 350, Cremophor® EL is distributed on the surface of Zeopharm**®** 600 after adsorption (Fig. [6c](#Fig6){ref-type="fig"}), which is responsible for the poor tabletability observed.Fig. 6SEM images of neat Zeopharm® 600 at 270× (**a**) and 2500× (**b**) magnifications and after adsorption with 1:1 w/w PEG-35 castor oil (Cremophor® EL) at 2200× (**c**) magnification. A microscope scale is shown with each image for comparison.

### Sipernat® 22 {#Sec19}

It is a precipitated silica with the reported particle size of 120 μm (Table [I](#Tab1){ref-type="table"}). The left hand column of Fig. [7](#Fig7){ref-type="fig"} shows the surface of Sipernat® 22 at 700× and 2500× (Fig. [7a and b](#Fig7){ref-type="fig"}, respectively), while the right hand column of the figure depicts the surface of the material at 1200× and 4300× (Fig. [7c and d](#Fig7){ref-type="fig"}, respectively) after the adsorption of Cremophor® EL at 1:1 w/w ratio. The particles appeared to be rigid with a relatively smooth surface and, unlike Neusilin® US2 discussed below, no relatively large pores were visible. When Cremophor® EL was adsorbed onto Sipernat® 22, it was inferred from the SEM pictures that the liquid might have formed a layer at the surface. The rigidity of the particles and the spreading of oily liquids at the surface of individual particles could be the possible reasons for poor tabletability of Sipernat® 22 before and after adsorption of Cremophor® EL.Fig. 7SEM images of neat Sipernat® 22 at 700× (**a**) and 2500× (**b**) magnifications and after adsorption of 1:1 w/w PEG-35 castor oil (Cremophor® EL) at 1200× (**c**) and 4300× (**d**) magnifications. Scales of individual images are shown for comparison.

### Neusilin® US2 {#Sec20}

The SEM micrographs of neat Neusilin® US2 at 1000×, 2300× and 5500× magnifications are shown in the left column of Fig. [8a, b and c](#Fig8){ref-type="fig"}, respectively. It is clearly evident from these figures that Neusilin® US2 is a granular and highly porous material with relatively large pores. Figure [8c](#Fig8){ref-type="fig"} indicates that the pore size could be as large as 1 μm in diameter. However, Neusilin® US2 has been reported in the literature to be mesoporous ([@CR7]). According to the IUPAC (International Union of Pure and Applied Chemistry) guidelines, mesoporous materials have pores in the range of 2--50 nm, while the pore size is \<2 nm for microporous materials and \>50 nm for macroporous materials ([@CR7]). Because of the small size, any micro- and meso-pores present in Neusilin® US2 would not be visible under SEM, and, therefore, the large pores observed in Fig. [8a, b and c](#Fig8){ref-type="fig"} indicate that Neusilin® US2 is also highly macroporous.Fig. 8SEM images of neat Neusilin® US2 at 1000× (**a**), 2300× (**b**) and 5500× (**c**) magnifications and 1:1 w/w mixture of Neusilin® US2 with PEG-35 castor oil (Cremophor® EL) at 1000× (**d**), 3000× (**e**) and 6500× (**f**) magnifications. Microscope scales are shown with the images for comparison of dimensions.

The macropores were still visible when Cremophor® EL was adsorbed onto Neusilin® US2 (Fig. [8d, e and f](#Fig8){ref-type="fig"}). Thus, it appears that most of the oily liquid was adsorbed into mesopores and deep into the channels of macropores of the silicate. A comparison of the SEM micrographs on the right hand side *versus* the left hand side column of Fig. [8](#Fig8){ref-type="fig"} indicates that the liquid might have also partially spread on the surface of particles. There was only the partial spreading of liquid at the surface of Neusilin® US2, the remaining being adsorbed within meso- and macro-pores below the surface. This may possibly explain why Neusilin® US2 lost tabletability only partially and still maintained acceptable tableting properties in comparison with other silicates where most of the liquid adsorbed on the surface.

As noted in Table [I](#Tab1){ref-type="table"}, Neusilin® US2 is a granular substance, and it is possible that its porosity is due to relatively large channels formed within the granules. Figure [9](#Fig9){ref-type="fig"} shows the effect of increasing Cremophor® EL content of the mixture on the surface of the silicate. When two parts of Cremophor® EL was mixed with 1 part of Neusilin® US2 (w/w), the liquid covered most of the pores and appeared to have also been deposited on the surface of the silicate (Fig. [9a, b and c](#Fig9){ref-type="fig"} at, respectively, 450×, 950× and 4000× magnifications). Further covering of the surface by Cremophor® EL is evident when its concentration was increased to 1:3 w/w (Fig. [9d, e and f](#Fig9){ref-type="fig"} at, respectively, 500×, 1000× and 3300× magnifications). Although materials at 1:2 and 1:3 silicate to surfactant ratios were still powders, they were, however, not tabletable due the presence of oily liquid at the surface that hindered inter-particulate bonding.Fig. 9SEM images of Neusilin® US2 loaded with 1:2 w/w PEG-35 castor oil (Cremophor® EL) at 450× (**a**), 950× (**b**) and 4000× (**c**) magnifications and loaded with 1:3 w/w Cremophor® EL at 500× (**d**), 1000× (**e**) and 3300× (**f**) magnifications. Microscopic scales are shown with the images for comparison.

### Neusilin® UFL2 {#Sec21}

Neusilin® UFL2 has similar chemical composition to that of Neusilin® US2; however, it reportedly has low particle size (Table [I](#Tab1){ref-type="table"}). The left hand column of Fig. [10](#Fig10){ref-type="fig"} shows the SEM images of neat Neusilin® UFL2 at 270×, 1000× and 6500× magnifications (Fig. [10a, b and c](#Fig10){ref-type="fig"}, respectively). The material is composed of the agglomerates of very fine particles. Even at the scale of 2 μm, it appears to be agglomerates (Fig. [10c](#Fig10){ref-type="fig"}) and, thus, it appears that the size of individual particles in Neusilin® UFL2 is in the submicron range (\<1 μm). With the addition of Cremophor® EL at 1:1 w/w ratio, it appeared that the liquid was adsorbed within the mesopores and macropores of the silicate, and, therefore, the material appeared to remain as fine particles (Fig. [10d, e and f](#Fig10){ref-type="fig"}). A close comparison between Fig. [10b and e](#Fig10){ref-type="fig"} indicates that there was also some agglomeration of powders, possibly because of the surface adsorption of liquid. Upon further increase of Neusilin® UFL2 to Cremophor® EL ratios to 1:2 and 1:3 w/w, the granulation progressed with the inter-particulate distribution of the liquid. Due to such an adsorption of oily liquids at the surface of and in between particles (Fig. [11](#Fig11){ref-type="fig"}), Neusilin® UFL2 does not demonstrate acceptable tabletability in presence of liquids (Fig. [1](#Fig1){ref-type="fig"}).Fig. 10SEM images of neat Neusilin® UFL2 at 270× (**a**), 1000× (**b**) and 6500× (**c**) magnifications and 1:1 w/w mixture of Neusilin® UFL2 with PEG-35 castor oil (Cremophor® EL) at 270× (**d**), 1500× (**e**) and 8000× (**f**) magnifications. Microscope scales are shown with the images for comparison of dimensions.Fig. 11SEM images of Neusilin® UFL2 loaded with 1:2 w/w PEG-35 castor oil (Cremophor® EL) at 700× (**a**) and 2300× (**b**) magnifications and loaded with 1:3 w/w Cremophor® EL at 650× (**c**) and 2500× (**d**) magnifications. Microscopic scales are shown with the images for comparison.

CONCLUSIONS {#Sec22}
===========

Although silicates are commonly used in the pharmaceutical dosage form development as glidants, there has been a recent interest in its application as adsorbents for the development of solid dosage forms of liquid lipid-based drug delivery systems. However, no systematic study has been conducted on whether various silicates available for pharmaceutical application are tabletable or not, whether the liquids are adsorbed on the surface or inside the pores of silicates, and what influence the adsoption of liquids have on their tabletability. Among the six silicates studied in the present investigation, three (Aerosil® 200, Sipernat® 22 and Sylysia® 350) were primarily composed of silicon dioxide and, when compressed in presence of 20% w/w microcrystalline cellulose, all of them were found to be non-tabletable as the tablets did not achieve a minimum tensile strength of 1 MPa at the wide range of compression pressure used. The adsorption of three different liquid components of lipid based drug delivery systems, namely, Capmul® MCM (glycerol monocaprylocaprate), Captex® 355 (caprylic/capric triglycerides) and Cremophor® EL (PEG-35 castor oil), at 1:1 w/w ratios showed that the mixtures still remained powders and their tabletability further decreased. The SEM images of mixtures with one of these liquids (Cremophor® EL) indicated that the adsorbed liquid remained primarily at the surface of particles rather than inside any pores and, as a result, the particles did not compact into tablets. Zeopharm® 600, another silicate used in the present investigation, is reported to contain calcium oxide (24% w/w) along with silicon dioxide (57% w/w) and it demonstrated good tabletability in absence of any adsorbed liquid. However, when Cremophor EL was adsorbed onto it at 1:1 w/w ratio, it lost its tabletability since the SEM micrographs demonstrated that the liquid was adsorbed onto the surface of solid particles creating inter-particulate barriers in physical bonding during compression. Neusilin® US2 and Neusilin® UFL2, which are the remaining two silicates used in the present investigation, are chemically similar containing mixtures of aluminum oxide (32%), magnesium oxide (12%) and silicon dioxide (32%). Both of them showed acceptable tabletability when compressed without the addition of a liquid lipid or surfactant. However, when Cremophor® EL was adsorbed onto these materials at 1:1 w/w, only Neusilin® US2 could retain acceptable tabletability while Neusilin® UFL2 demonstrated minimally acceptable tabletability only at a low compression pressure of 45 MPa and it failed to demonstrate acceptable tabletability when the compression pressure was increased. These results could be explained by the SEM photomicrographs, which showed that the liquid was adsorbed into the pores of relatively large particles of Neusilin® US2, while in case of Neusilin® UFL2 the liquid was distributed at the surface.

From the above summary, a trend appears in the mechanism of tabletability of different silicates. The silicates used in the present study can be divided into two chemical groups: one containing 98--100% silicon dioxide (Aerosil® 200, Sipernat® 22 and Sylysia® 350), and the other containing much lesser amount of silicon dioxide (32--57%), the rest being aluminum oxide, magnesium oxide or calcium oxide (Neusilin US2, Neusilin UFL2 and Zeopharm 600). In the absence of adsorbed liquids, the second group was tabletable, while the first was not. Thus, the chemical composition plays a major role in the tabletability of silicates. Since there were big differences in particle sizes of Neusilin® US2, Neusilin® UFL2 and Zeopharm® 600 , it appeared that the particle size did not have major influence on the tabletability of silicates in the absence of adsorbed liquids . However, whether these silicates would retain their tabletability after adsorption of liquids appears to be dependent on particle size and possibly porosity. This is evident from the greater loss of tabletability of Neusilin® UFL2 and Zeopharm® 600 (silicates with lower particle size) than that of Neusilin® US2 (silicate with larger particle size). The porosity might be important as the porous channels could be deeper in larger particles to retain the adsorbed lipids during compression. Further studies are, however, needed to elucidate mechanisms of why and how the chemical composition influences the tabletability of silicates and the effect of particle size and porosity on the tabletability after the adsorption of lipidic materials.

It may be concluded that, among all the silicates used in the present investigation, only Neusilin® US2 has both the surface morphology and the porosity for use as the carrier in the development of tablet formulations of lipid-based drug delivery systems. The amount of liquid lipidic materials used should, however, be limited. When the ratio of Neusilin® US to the liquid was 1:1 w/w, there was acceptable tabletability, and it decreased below the acceptable limit when the liquid component was increased to 1:2 and 1:3 w/w ratios. It is hoped that the systematic approach adopted in the present investigation will help the selection of silicates from those currently available commercially. It may also provide guidance for the synthesis of newer silicates for the development of tablets containing lipid components.
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